Carrie De Hoff

Suggest Changes
Learn More
PURPOSE On the basis of preclinical studies, we hypothesized that interleukin (IL)12 would potentiate the antitumor actions of an antihuman epidermal growth factor receptor-2 (HER2) monoclonal(More)
  • 1